LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 103 filers reported holding LEXICON PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.08 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $4,000 | -42.9% | 1,043 | -53.5% | 0.00% | – |
Q3 2019 | $7,000 | -50.0% | 2,245 | 0.0% | 0.00% | – |
Q2 2019 | $14,000 | -58.8% | 2,245 | -63.9% | 0.00% | – |
Q1 2019 | $34,000 | -17.1% | 6,211 | +2.7% | 0.00% | – |
Q4 2018 | $41,000 | -39.7% | 6,048 | -5.0% | 0.00% | -100.0% |
Q3 2018 | $68,000 | +19.3% | 6,365 | -3.9% | 0.00% | 0.0% |
Q2 2018 | $57,000 | 0.0% | 6,623 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $57,000 | +5.6% | 6,623 | +21.2% | 0.00% | 0.0% |
Q4 2017 | $54,000 | +315.4% | 5,464 | +419.4% | 0.00% | – |
Q3 2017 | $13,000 | -72.3% | 1,052 | -63.5% | 0.00% | -100.0% |
Q2 2017 | $47,000 | +213.3% | 2,880 | +172.7% | 0.00% | – |
Q1 2017 | $15,000 | -21.1% | 1,056 | -22.1% | 0.00% | – |
Q4 2016 | $19,000 | -20.8% | 1,356 | +0.2% | 0.00% | – |
Q3 2016 | $24,000 | -11.1% | 1,353 | -29.2% | 0.00% | – |
Q2 2016 | $27,000 | +17.4% | 1,910 | +0.7% | 0.00% | – |
Q1 2016 | $23,000 | +27.8% | 1,896 | +36.8% | 0.00% | – |
Q4 2015 | $18,000 | +63.6% | 1,386 | +38.6% | 0.00% | – |
Q3 2015 | $11,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ulys, L.L.C. | 4,321,214 | $42,694,000 | 100.00% |
Artal Group S.A. | 58,274,650 | $575,754,000 | 8.68% |
SECTOR GAMMA AS | 837,192 | $8,271,000 | 1.39% |
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 35,714 | $353,000 | 1.36% |
Virtus ETF Advisers LLC | 95,079 | $939,000 | 1.18% |
NEA Management Company, LLC | 2,382,286 | $23,537,000 | 0.98% |
USS Investment Management Ltd | 3,507,900 | $34,676,000 | 0.40% |
Malaga Cove Capital, LLC | 59,387 | $587,000 | 0.33% |
CLEARBRIDGE, LLC | 1,189,097 | $11,748,000 | 0.24% |
WEDBUSH SECURITIES INC | 139,106 | $1,374,000 | 0.17% |